Project Details
| Status | Active |
|---|---|
| Effective start/end date | 19/06/24 → 18/06/29 |
HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects with Locally Advanced or Metastatic Solid Tumors
- Frentzas, Sophia (Primary Chief Investigator (PCI))
Project: Research